|
|
1.
|
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
Year: 2014
Citation: - Cancer. 120(17):2657-64, 2014 Sep 1.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, Non-U.S. Gov't
All authors: - Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
|
|
|
2.
|
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
Year: 2017
Citation: - JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
